Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.79K Buy
77
+61
+381% +$7.19K ﹤0.01% 668
2026
Q2
$1.71K Sell
16
-53
-77% -$6.42K ﹤0.01% 809
2026
Q1
$11.3K Buy
69
+1
+1% +$154 ﹤0.01% 608
2025
Q4
$11.8K Buy
+68
New +$12.4K ﹤0.01% 612

Other funds holding INSM

Grove Bank & Trust's INSM Position: Q3 2026 in Review

Grove Bank & Trust increased its Insmed (INSM) stake by 381% in Q3 2026, buying an estimated $7.19K and bringing the position to 77 shares worth $8.79K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Grove Bank & Trust first reported a position in INSM in Q4 2025 and has held it in 4 quarters since. The position peaked at $11.8K in Q4 2025. 16 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Grove Bank & Trust held 77 shares of Insmed worth $8.79K as of Q3 2026.
  • Grove Bank & Trust bought 61 Insmed shares in Q3 2026, an estimated $7.19K.
  • Insmed made up ﹤0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #668 holding.
  • Grove Bank & Trust first reported a position in Insmed in Q4 2025 and has held it in 4 quarters since.
  • Grove Bank & Trust's Insmed position peaked at $11.8K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.